BCMA — Targeted Therapies, Trials & Pipeline
B-cell maturation antigen — a myeloma-restricted target for CAR-T cells, bispecifics and ADCs.
Approved drugs targeting BCMA
belantamab mafodotin
·
ciltacabtagene autoleucel
·
elranatamab
·
idecabtagene vicleucel
·
linvoseltamab
·
teclistamab
Investigational pipeline agents
Alnuctamab
·
Anitocabtagene autoleucel
·
CB-011
·
Cevostamab
·
Etentamig
·
GC012F
·
ISB 2001
·
JNJ-79635322
·
RO7297089
Landmark trials
CARTITUDE-4
·
KarMMa-3
·
CARTITUDE-1
·
DREAMM-2